Lina N. Huang

Montreal, QC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Corrigendum dans la 'Directive clinique no 422a : Ménopause : symptômes vasomoteurs, agents thérapeutiques d'ordonnance, médecines douces et complémentaires, nutrition et mode de vie' [J Obstet Gynaecol Can. 43 (2021) 1205-1223.E1].

Corrigendum dans la 'Directive clinique no 422a : Ménopause : symptômes vasomoteurs, agents thérapeutiques d'ordonnance, médecines douces et complémentaires, nutrition et mode de vie' [J Obstet Gynaecol Can. 43 (2021) 1205-1223.E1].

Journal: Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC

Published: July 21, 2024

Corrigendum to 'Guideline No. 422a: Menopause: Vasomotor Symptoms, Prescription Therapeutic Agents, Complementary and Alternative Medicine, Nutrition, and Lifestyle' [J Obstet Gynaecol Can 43 (2021) 1188-1204].

Corrigendum to 'Guideline No. 422a: Menopause: Vasomotor Symptoms, Prescription Therapeutic Agents, Complementary and Alternative Medicine, Nutrition, and Lifestyle' [J Obstet Gynaecol Can 43 (2021) 1188-1204].

Journal: Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC

Published: February 19, 2022

Quality and readability of online health information on menopausal hormone therapy in Canada: what are our patients reading?

Quality and readability of online health information on menopausal hormone therapy in Canada: what are our patients reading?

Journal: Menopause (New York, N.Y.)

Published: December 14, 2021

Directive clinique no 422a : Ménopause : symptômes vasomoteurs, agents thérapeutiques d'ordonnance, médecines douces et complémentaires, nutrition et mode de vie.

Directive clinique no 422a : Ménopause : symptômes vasomoteurs, agents thérapeutiques d'ordonnance, médecines douces et complémentaires, nutrition et mode de vie.

Journal: Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC

Published: October 15, 2021

Guideline No. 422a: Menopause: Vasomotor Symptoms, Prescription Therapeutic Agents, Complementary and Alternative Medicine, Nutrition, and Lifestyle.

Guideline No. 422a: Menopause: Vasomotor Symptoms, Prescription Therapeutic Agents, Complementary and Alternative Medicine, Nutrition, and Lifestyle.

Journal: Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC

Published: August 14, 2021

Does hormonal therapy for fertility preservation affect the survival of young women with early-stage endometrial cancer?

Does hormonal therapy for fertility preservation affect the survival of young women with early-stage endometrial cancer?

Journal: Cancer

Published: August 10, 2016

Response: IVF and intrauterine insemination cannot be compared.

Response: IVF and intrauterine insemination cannot be compared.

Journal: Reproductive biomedicine online

Published: March 24, 2015

Predictors of in vitro fertilization outcomes in women with highest follicle-stimulating hormone levels ≥ 12 IU/L: a prospective cohort study.

Predictors of in vitro fertilization outcomes in women with highest follicle-stimulating hormone levels ≥ 12 IU/L: a prospective cohort study.

Journal: PloS one

Published: January 05, 2015

Should IVF be used as first-line treatment or as a last resort? A debate presented at the 2013 Canadian Fertility and Andrology Society meeting.

Should IVF be used as first-line treatment or as a last resort? A debate presented at the 2013 Canadian Fertility and Andrology Society meeting.

Journal: Reproductive biomedicine online

Published: May 07, 2014

Showing 1-9 of 9

Last Updated: 09/26/2026